Global Health Limited (Medanta) has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding scheduled meetings with investors and analysts. The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Company's Management will meet Investors/Analysts in meetings organized by Nuvama Institutional Equities according to the following schedule:
- Date: June 24, 2026 | Type: one to one | Place: Noida | Mode: In Person
- Date: June 25, 2026 | Type: one to one | Place: Gurugram | Mode: In Person
- Date: June 26, 2026 | Type: one to one | Place: Lucknow | Mode: In Person
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during these meetings. The notice includes a disclaimer that the meetings are subject to change in case of any unforeseen circumstances on the part of Analysts, Investors, or the Company.
The intimation was digitally signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), on June 18, 2026, at 15:04:01 IST.